Simona Soverini
0000-0002-4508-0353
Publication & Citation Trends
Publications
561 total
Nilotinib versus imatinib with early switch from imatinib to nilotinib to obtain treatment-free remission in newly diagnosed chronic myeloid leukemia patients: the analysis of the first co-primary endpoint
Cited by 0
Semantic Scholar
Outcome of Chronic Myeloid Leukemia Patients Not in Deep Molecular Response: Results From the GIMEMA LabNet CML Network Database
Cited by 0
Semantic Scholar
International, prospective study comparing nilotinib versus imatinib with early switch to nilotinib to obtain sustained treatment-free remission (TFR) in patients with chronic myeloid leukemia: The tfr rate at the end of follow-up
Cited by 0
Semantic Scholar
2025 European LeukemiaNet recommendations for the management of chronic myeloid leukemia
Cited by 54
Semantic Scholar
Different kinetic behavior of molecular reduction by BCR::ABL1 transcript types in frontline treatment of chronic myeloid leukemia patients: A GIMEMA labnet CML network database survey.
Cited by 0
Semantic Scholar
How I Evaluate and Treat Resistance and Relapse in CML.
Cited by 1
Semantic Scholar
SETD2 deficiency in chronic myeloid leukemia (CML) contributes to tyrosine kinase inhibitor (TKI) resistance and disease acceleration by enhancing genetic instability and rewiring cellular metabolism and might be a novel biomarker of high risk disease since diagnosis
Cited by 0
Semantic Scholar
Molecular Outcome of Chronic Myeloid Leukemia Affected Patients Not in Deep Molecular Response: The “Others” from the Gimema Labnet Network
Cited by 0
Semantic Scholar
Research Topics
Chronic Myeloid Leukemia Treatments
(410)
Chronic Lymphocytic Leukemia Research
(313)
Acute Lymphoblastic Leukemia research
(159)
Eosinophilic Disorders and Syndromes
(118)
Acute Myeloid Leukemia Research
(89)
Affiliations
University of Siena
South Australia Pathology
University of Verona
Polytechnic University of Turin
University of Mannheim